StockData
Tandem Diabetes Care Inc logo

Tandem Diabetes Care Inc (TNDM) stock

TNDMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3030% below fair value
$17.06−1.42 (-7.68%)

Close on Nov 17, 2026Market cap $1.19BP/E –Yield –

Tandem Diabetes Care profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Tandem Diabetes Care's profit margin for the twelve months ending Jun 30, 2026 was -6.1%. For fiscal 2025 it was -20.2%, against -10.2% the year before. The highest annual figure on record is 2.2% in fiscal 2021.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-20.2%−10.0
FY2024Dec 31, 2024-10.2%+19.6
FY2023Dec 31, 2023-29.8%−18.0
FY2022Dec 31, 2022-11.8%−14.0
FY2021Dec 31, 20212.2%+9.1
FY2020Dec 31, 2020-6.9%−0.1
FY2019Dec 31, 2019-6.8%+59.9
FY2018Dec 31, 2018-66.7%+1.2
FY2017Dec 31, 2017-67.9%+31.2
FY2016Dec 31, 2016-99.0%+0.4
FY2015Dec 31, 2015-99.4%+60.5
FY2014Dec 31, 2014-159.9%+57.7
FY2013Dec 31, 2013-217.7%+1116.3
FY2012Dec 31, 2012-1333.9%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-8.3%+13.5
Q1 FY2026Mar 31, 2026-8.2%+47.4
Q4 FY2025Dec 31, 2025-0.2%−0.5
Q3 FY2025Sep 30, 2025-8.5%+1.0
Q2 FY2025Jun 30, 2025-21.8%−7.9
Q1 FY2025Mar 31, 2025-55.7%−33.4
Q4 FY2024Dec 31, 20240.3%+15.5
Q3 FY2024Sep 30, 2024-9.5%+8.2
Q2 FY2024Jun 30, 2024-13.9%+4.4
Q1 FY2024Mar 31, 2024-22.3%+50.8
Q4 FY2023Dec 31, 2023-15.2%−8.1
Q3 FY2023Sep 30, 2023-17.8%+6.2
Q2 FY2023Jun 30, 2023-18.3%−10.7
Q1 FY2023Mar 31, 2023-73.1%−64.8
Q4 FY2022Dec 31, 2022-7.2%−12.3
Q3 FY2022Sep 30, 2022-23.9%−27.2
Q2 FY2022Jun 30, 2022-7.5%−9.8
Q1 FY2022Mar 31, 2022-8.4%−4.8
Q4 FY2021Dec 31, 20215.1%−5.0
Q3 FY2021Sep 30, 20213.2%+10.8
Q2 FY2021Jun 30, 20212.3%+27.1
Q1 FY2021Mar 31, 2021-3.6%+11.6
Q4 FY2020Dec 31, 202010.1%+7.7
Q3 FY2020Sep 30, 2020-7.6%−4.5
Q2 FY2020Jun 30, 2020-24.8%−23.2
Q1 FY2020Mar 31, 2020-15.2%+19.7
Q4 FY2019Dec 31, 20192.4%−2.4
Q3 FY2019Sep 30, 2019-3.1%+71.0
Q2 FY2019Jun 30, 2019-1.6%+172.3
Q1 FY2019Mar 31, 2019-34.8%+85.0
Q4 FY2018Dec 31, 20184.8%+33.1
Q3 FY2018Sep 30, 2018-74.0%−14.6
Q2 FY2018Jun 30, 2018-173.9%−71.7
Q1 FY2018Mar 31, 2018-119.9%+5.5
Q4 FY2017Dec 31, 2017-28.3%+23.0
Q3 FY2017Sep 30, 2017-59.4%+183.2
Q2 FY2017Jun 30, 2017-102.2%–
Q1 FY2017Mar 31, 2017-125.4%–
Q4 FY2016Dec 31, 2016-51.3%–
Q3 FY2016Sep 30, 2016-242.5%–

More Tandem Diabetes Care figures

See a number that looks wrong?